|
||||||||||||||||
|
||||||||||||||||
| HUM-MOLGEN -> mail archive | Search | register for news alert (free) | |||||||||||||||
| Hans Goerl: ETHI: BRCA2 patenting | ||||||||||||||||
|
[Author Prev][Author Next][Thread Prev][Thread Next][Author Index][Topic Index] |
||||||||||||||||
|
To: Multiple recipients of list HUM-MOLGEN <HUM-MOLGEN@NIC.SURFNET.NL> Subject: ETHI: BRCA2 patenting From: Hans Goerl <GENETHICS@delphi.com> Date: Thu, 28 Dec 1995 23:50:39 -0500
From: JMARX <JMARX@AAAS.ORG>
As a reporter for the journal Science, I am working on a story about
the discovery of BRCA2, and would certainly like to hear comments
about the dispute, especially from the principals on the U.K. side,
who have been extremely hard to contact, as a result of the holidays.
Thank you,
Jean Marx
|
||||||||||||||||
|
||||||||||||||||
|
Mail converted by |
||||||||||||||||